Protective antibodies
Showing 1 - 25 of 6,677
Closely Grouped, Iterative Exposures to Suxamethonium During ECT
Recruiting
- Depression
- +2 more
- Iterative exposure to suxamethonium during ECT sessions
-
Paris, FranceSaint-Antoine Hospital
Apr 4, 2022
Sirolimus on Immunizations During Treatment of Kaposiform
Recruiting
- Kaposiform Hemangioendothelioma
-
Shanghai, Shanghai, ChinaChildren's Hospital of Fudan University
Apr 22, 2022
SARS-CoV-2 Vaccination on Cancer Patients Infected With
Recruiting
- COVID-19 Infection
- COVID-19 Vaccine
- no intervention
-
Beijing, Beijing, ChinaSanhuan Cancer Hospital, Chaoyang District, Beijing(Cancer Hospi
Mar 7, 2023
Plasmodium Falciparum Malaria Trial in Bandarban, Lama (DHA/piperaquine and a SLD-PQ, Study vaccine R21/Matrix-M™)
Not yet recruiting
- Plasmodium Falciparum Malaria
- DHA/piperaquine and a SLD-PQ
- Study vaccine R21/Matrix-M™
-
Bāndarban, Bangladesh
- +1 more
Sep 28, 2023
SARS-CoV-2 Trial in Bengbu (SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine, Saline solution)
Recruiting
- SARS-CoV-2
- SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine
- Saline solution
-
Bengbu, Anhui, ChinaFirst Affiliated Hospital Bengbu Medical College
Feb 26, 2023
IsThird Dose of MMRV Vaccine Beneficial for Adult Population in
Not yet recruiting
- Vaccination Failure
- Vaccine Response Impaired
- Serology for antibody levels - Baseline
- +3 more
- (no location specified)
Jun 26, 2023
HIV-1-infection Trial in Amsterdam (ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes)
Active, not recruiting
- HIV-1-infection
- ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes
-
Amsterdam, Noord-Holland, NetherlandsAmsterdam University Medical Centers, location AMC
Jan 31, 2023
Prevention of COVID-19 Caused by SARS-CoV-2 Trial in Chengdu (randomized, double-blinded, -controlled)
Active, not recruiting
- Prevention of COVID-19 Caused by SARS-CoV-2
- randomized, double-blinded, placebo-controlled
-
Chengdu, ChinaWest China Second University Hospital
Jan 9, 2023
Antiphospholipid Antibodies and Microparticles in Immune
Not yet recruiting
- Thrombosis
- Antiphospholipid antibodies
- (no location specified)
Apr 25, 2023
Anti-COVID-19 Humoral and Memory T Cell Responses in Various
Active, not recruiting
- Immune Response
- blood collection
-
Paris, FranceHôpital Robert Debré
Sep 15, 2022
Convalescent Plasma for COVID-19 Research Donor Study
Active, not recruiting
- Covid19
-
Toronto, Ontario, CanadaThe Hospital for Sick Children
Oct 24, 2022
Clostridium Infection Trial in Paris (Collection of peripheral blood mononuclear cells)
Completed
- Clostridium Infection
- Collection of peripheral blood mononuclear cells
-
Paris, FranceMaladies infectieuses et tropicales, Hôpital Pitié-Salpêtrière
Oct 3, 2022
Vaccine-Preventable Diseases, Herpes Zoster Trial in Zhenjiang (Recombinant Herpes Zoster Vaccine, Recombinant Herpes Zoster
Recruiting
- Vaccine-Preventable Diseases
- Herpes Zoster
- Recombinant Herpes Zoster Vaccine
- Recombinant Herpes Zoster Vaccine Placebo
-
Zhenjiang, Jiangsu, ChinaJiangsu Province Center for Disease Control and Prevention (Chin
Oct 12, 2023
Workforce Serosurveillance to Track Long-term Modifications to
Enrolling by invitation
- Covid19
- Antibody testing
-
Great Neck, New YorkFeinstein Institutes for Medical Research, Northwell Health
Sep 26, 2022
SARS-CoV-2, Serology, Students Trial in Bloomington (Immediate vs. delayed provision of antibody test results)
Completed
- SARS-CoV-2
- +2 more
- Immediate vs. delayed provision of antibody test results
-
Bloomington, IndianaIndiana University
Jan 27, 2022
Malaria Trial in Baltimore (MAM01, Placebo)
Not yet recruiting
- Malaria
- MAM01
- Placebo
-
Baltimore, MarylandCenter for Vaccine Development and Global Health, 685 W. Baltimo
May 26, 2023
Vaccination, Hematopoietic Stem Cells Trial in Lyon, Pierre-Bénite (immune biomarkers to evaluate vaccine response in HSCT
Active, not recruiting
- Vaccination
- Hematopoietic Stem Cells
- immune biomarkers to evaluate vaccine response in HSCT recipients
-
Lyon, France
- +1 more
Jun 15, 2022
HIV-1-infection Trial in London (ConM SOSIP, EDC ConM SOSIP, ConS UFO)
Active, not recruiting
- HIV-1-infection
- ConM SOSIP
- +4 more
-
London, United KingdomNIHR Imperial Clinical Resarch Facility
Jul 25, 2022
Coronavirus Disease 2019 Trial in Buenos Aires (serology)
Completed
- Coronavirus Disease 2019
- serology
-
Buenos Aires, Ciudad De Buenos Aires, ArgentinaHospital de Niños Ricardo Gutierrez
Aug 23, 2021
Schistosoma Mansoni, Schistosomiasis Trial (Sm-p80 + GLA-SE Vaccine, Placebo, Schistosoma mansoni infection)
Not yet recruiting
- Schistosoma Mansoni
- Schistosomiasis
- Sm-p80 + GLA-SE Vaccine
- +2 more
- (no location specified)
Aug 11, 2023
Home Monitoring of Fetal Heart Rate in SSA+ Pregnant Women
Recruiting
- Pregnancy Related
- +5 more
-
Milano, ItalyASST Fatebenefratelli e Sacco
Jul 13, 2023
COVID-19 IgG Formation in Physicians at ALGH and Their Household
Completed
- Covid19
- +2 more
- Screening
-
Park Ridge, IllinoisAdvocate Lutheran General Hospital
Feb 14, 2022
Monitoring the IgG/IgM Antibodies in COVID-19 Patients
Completed
- COVID-19 Infections
- Serodiagnosis of IgG and IgM
-
Bhakkar, Punjab, Pakistan
- +1 more
Jul 18, 2022
Rotavirus, Diarrhea Trial in Ho Chi Minh (Rotarix vaccine)
Completed
- Rotavirus
- Diarrhea
- Rotarix vaccine
-
Ho Chi Minh, VietnamHung Vuong Hospital
Nov 10, 2022
Female HPV Vaccination in China
Recruiting
- Human Papillomavirus Vaccines
- +4 more
-
Fuzhou, Fujian, China
- +5 more
Jul 5, 2023